HAL p.Thr229Ile
c.686C>T · rs143844261 · VCV310717
Computational evidence
| Protein change | ||
| AlphaMissense | 0.2665 | likely benign |
|---|---|---|
| REVEL | 0.673 | pathogenic-leaning |
| SaProt | LLR -7.98 | tolerated |
| ⇒ REVEL calls this damaging; AlphaMissense and SaProt do not. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 12 | GERP 1.2, phastCons 1 |
| Regional constraint | o/e 0.95 | unconstrained · MANE · 22 kb · p 0.18 · regional, not allelic |
| Overall | ||
| CADD | 24.3 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Ashkenazi Jewishnot grpmax-eligible | 0.26% | 384 |
| Middle Easterngrpmax | 0.0329% | 3,039 |
| Remaining individualsnot grpmax-eligible | 0.032% | 3,121 |
| European (non-Finnish) | 0.0292% | 3,427 |
| Admixed American | 0.015% | 6,666 |
| Finnishnot grpmax-eligible | 0.00937% | 10,668 |
| African / African-American | 0.00534% | 18,723 |
| South Asian | 0.0022% | 45,533 |
Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- HAL
- Protein
- p.Thr229Ile
- Coding
- c.686C>T
- MANE Select
- NM_002108
- dbSNP
- rs143844261
- Type
- single nucleotide variant
- Location
- chr12:95992709 (GRCh38)
- Gene constraint
- LOEUF 1.213 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 90.83
Disease context
histidinemia — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Histidinemia (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- Infancy, Neonatal
- Prevalence
- 1-9 / 100 000 (Sweden)
Similar variants
- HAL c.*392C>T Uncertain significance ★★ same condition
- HAL p.Arg9Cys Uncertain significance ★★ ⚠ same condition
- HAL p.Asn476Lys Uncertain significance ★★ ⚠ same condition
- HAL p.Glu472Lys Uncertain significance ★★ ⚠ same condition
- HAL p.Gly165Ser Uncertain significance ★★ ⚠ same condition
- HAL p.Leu242Met Uncertain significance ★★ ⚠ same condition
- HAL p.Phe485Leu Uncertain significance ★★ ⚠ same condition
- HAL p.Thr123Met Uncertain significance ★★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/hal-p-thr229ile (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown